-
Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient
Dataset
EGAD00001005882
-
Genome and transcriptome sequence data from a malignant choroid melanoma patient
Dataset
EGAD00001005883
-
Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient
Dataset
EGAD00001005884
-
Genome and transcriptome sequence data from a large intestine-colon cancer patient
Dataset
EGAD00001005885
-
Genome and transcriptome sequence data from a colorectal adenocarcinoma patient
Dataset
EGAD00001005886
-
Genome and transcriptome sequence data from a parotid gland adenoid cystic carcinoma patient
Dataset
EGAD00001005887
-
Genome and transcriptome sequence data from a breast carcinoma patient
Dataset
EGAD00001005888
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005889
-
Genome and transcriptome sequence data from a melanoma patient
Dataset
EGAD00001005890
-
Genome and transcriptome sequence data from a thyroid hurthle cell carcinoma patient
Dataset
EGAD00001005891
-
Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient
Dataset
EGAD00001005892
-
Genome and transcriptome sequence data from a pancreatic cancer patient
Dataset
EGAD00001005893
-
Genome and transcriptome sequence data from a ewing sarcoma patient
Dataset
EGAD00001005894
-
Genome and transcriptome sequence data from a cecum adenocarcinoma patient
Dataset
EGAD00001005895
-
Genome and transcriptome sequence data from a pancreatic cancer patient
Dataset
EGAD00001005896
-
Genome and transcriptome sequence data from a metastatic adrenocortical cancer patient
Dataset
EGAD00001005897
-
Genome and transcriptome sequence data from a malignant peripheral nerve sheath tumor patient
Dataset
EGAD00001005898
-
Genome and transcriptome sequence data from an endometrial stromal sarcoma patient
Dataset
EGAD00001005899
-
Genome and transcriptome sequence data from a hemangioma patient
Dataset
EGAD00001005900
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005901
-
Genome and transcriptome sequence data from a pancreatic cancer patient
Dataset
EGAD00001005902
-
Genome and transcriptome sequence data from a metastatic gallbladder adenocarcinoma patient
Dataset
EGAD00001005903
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005904
-
Genome and transcriptome sequence data from an adenocarcinoma patient
Dataset
EGAD00001005905
-
Genome and transcriptome sequence data from a metastatic clear cell carcinoma of the ovary patient
Dataset
EGAD00001005906
-
MutWP5: CRUK Mutographs of Cancer: Breast: BRCA Carriers (Targeted) (2020-01-29)
Dataset
EGAD00001005920
-
MutWP5: CRUK Mutographs of Cancer: Breast: BRCA Carriers (Exome) (2020-01-29)
Dataset
EGAD00001005921
-
MutWP5: CRUK Mutographs of Cancer: Breast: Cancer Mastectomy (WG) (2020-01-29)
Dataset
EGAD00001005922
-
MutWP5: CRUK Mutographs of Cancer: Breast: Cancer Mastectomy (Targeted) (2020-01-29)
Dataset
EGAD00001005923
-
MutWP5: CRUK Mutographs of Cancer: Lung: PD38234 (Targeted) (2020-01-29)
Dataset
EGAD00001005925
-
MutWP5: CRUK Mutographs of Cancer: Breast: Cancer Mastectomy (Exome) (2020-01-29)
Dataset
EGAD00001005924
-
cfRRBS on cfDNA from pediatric cancer patients
Dataset
EGAD00001005928
-
Whole-exome sequences of ovarian clear cell carcinomas and paired normal DNA
Dataset
EGAD00001006004
-
108 samples liver cancer and normal controls (54 pairs), whole exome sequencing
Dataset
EGAD00001006005
-
WES
Dataset
EGAD00001006009
-
Sequencing data for oesophageal samples - Killcoyne, Gregson et al (sWGS)
Dataset
EGAD00001006033
-
NICHE - DNA-seq of MMR proficient and MMR deficient early stage colon cancers
Dataset
EGAD00001006041
-
NICHE - RNA-seq of MMR proficient and MMR deficient early stage colon cancers
Dataset
EGAD00001006042
-
Neoplastic pancreatic cysts and associated cancers
Dataset
EGAD00001006229
-
Distribution of ctDNA levels in plasma of early-stage non-small cell lung cancer patients measured using personalised ctDNA analysis
Dataset
EGAD00001006230
-
Cancer Alliance WGS
Dataset
EGAD00001006233
-
Cancer Alliance RNA-Seq PolyA
Dataset
EGAD00001006234
-
Cancer Alliance RNA-Seq total RNA
Dataset
EGAD00001006235
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Dataset
EGAD00001006237
-
RNA-seq data from 121 tumor samples with muscle invasive bladder cancer.
Dataset
EGAD00001006238
-
WES data from 165 tumor/germline samples with muscle invasive bladder cancer.
Dataset
EGAD00001006239
-
RNA-seq data of breast cancer HCI011 model from Ros et al (2020)
Dataset
EGAD00001006245
-
SPECTA Lung cancer VCF files
Dataset
EGAD00001006260
-
RNA-Seq of serially passaged TIC-enriched spheres of colorectal cancer
Dataset
EGAD00001006264
-
WGS data of serially passaged TIC-enriched spheres of colorectal cancer
Dataset
EGAD00001006265
-
WES data of serially passaged TIC-enriched spheres of colorectal cancer
Dataset
EGAD00001006266
-
Single cell transcriptomes of of primary tumors and normal endometrial derived organoids treated with DBZ
Dataset
EGAD00001006280
-
Single Cell RNAseq of PBMC from renal cancer patients
Dataset
EGAD00001006175
-
Single cell RNAseq of PBMC from bladder cancer patients
Dataset
EGAD00001006182
-
Competitive selection of somatic mutant clones in normal human skin varies with body site
Dataset
EGAD00001006194
-
Processed RNA-seq data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006199
-
Phenotype data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006200
-
Genotype data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006201
-
Raw RNA-seq data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006205
-
Elevated somatic mutation burdens in normal human cells due to defective DNA polymerases
Dataset
EGAD00001006212
-
Heterogeneous Genomic Evolution and Immune Microenvironments in Metastatic Lung Cancer
Dataset
EGAD00001006213
-
Whole exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
Dataset
EGAD00001006217
-
February 2020 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium.
Dataset
EGAD00001006220
-
SPECTA Lung cancer RNA FASTQ files
Dataset
EGAD00001006222
-
SPECTA Lung cancer DNA FASTQ files
Dataset
EGAD00001006223
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in peripheral blood from breast cancer patients and healthy individuals.
Study
EGAS00001002699
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Sensitive and Frequent Identification of High Avidity Neo-epitope Specific CD8 + T-cells in Immunotherapy-naïve Ovarian Cancer
Study
EGAS00001002803
-
“Castration-persistence” is a distinct state of tolerance to androgen receptor targeting therapies in prostate cancer
Study
EGAS00001003172
-
Genome-wide cell-free DNA fragmentation in patients with cancer
Study
EGAS00001003611
-
FOXM1 is a biomarker of resistance to PI3Kα inhibition in ER+ breast cancer that is detectable using metabolic imaging (RNA-seq data)
Study
EGAS00001004452
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001004407
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in breast tumors from breast cancer patients.
Study
EGAS00001004671
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Single-cell profiling of neoantigen-specific T cells in lung cancers treated with neoadjuvant PD-1 blockade
Study
EGAS00001005343
-
RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors
Study
EGAS00001005588
-
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers
Study
EGAS00001005676
-
Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer
Study
EGAS00001005736
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
Study
EGAS00001006251
-
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration.
Study
EGAS00001006652
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (H021)
Study
EGAS00001006706
-
Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guérin
Study
EGAS00001006879
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Study
EGAS00001007877
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Study
EGAS00001007242
-
Clinical outcomes and immune correlates of response to nivolumab plus chemoradiotherapy in women with locally-advanced cervical cancer – NiCOL study
Study
EGAS00001007297
-
Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumors
Study
EGAS00001007327
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
Cancer Alliance Exome
Dataset
EGAD00001006236
-
SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors
Study
EGAS00001007590
-
Genome-wide association study identifies common variants associated with breast cancer in South African Black women
Study
EGAS00001008032